Literature DB >> 17762904

Measurement of quality of life in schizophrenia: a comparison of two scales.

Yvette Kusel1, Richard Laugharne, Sian Perrington, Jan McKendrick, Deborah Stephenson, J Stockton-Henderson, Madeline Barley, R McCaul, Tom Burns.   

Abstract

BACKGROUND: People with schizophrenia have an impaired quality of life (QoL), and various QoL assessment scales are available. However it is not clear which scale should be used in different situations. We aimed to compare a patient-rated subjective QoL scale with an observer-rated QoL scale by measuring their degree of correlation and their respective associative profiles with outcome measures.
METHOD: Patients of the UK Schizophrenia Care and Assessment Program completed a patient-rated QoL questionnaire (MANSA). Research staff completed the observer-rated QoL tool (QLS) as part of an assessment of symptomatology and functioning.
RESULTS: The two QoL tools were moderately positively correlated (r = 0.39). Both scales were negatively correlated with positive and negative symptoms of schizophrenia and depressive symptoms, and positively correlated with functioning scores. However the two scales were influenced by different factors. The patient-rated QoL was more significantly influenced by depressive symptoms, and the observer-rated QoL was more heavily influenced by negative symptoms.
CONCLUSIONS: Patient-rated and observer-rated QoL are moderately related, with a number of joint determinants, but the former is sensitive to depressive influences, whilst the latter is sensitive to the negative symptomatology of schizophrenia.

Entities:  

Mesh:

Year:  2007        PMID: 17762904     DOI: 10.1007/s00127-007-0249-1

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  21 in total

1.  Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization.

Authors:  C C Bow-Thomas; D I Velligan; A L Miller; J Olsen
Journal:  Psychiatry Res       Date:  1999-05-31       Impact factor: 3.222

2.  Determinants of quality of life at first presentation with schizophrenia.

Authors:  S Browne; M Clarke; M Gervin; J L Waddington; C Larkin; E O'Callaghan
Journal:  Br J Psychiatry       Date:  2000-02       Impact factor: 9.319

3.  Quality of life in first-admitted schizophrenia patients: a follow-up study.

Authors:  S Priebe; U U Roeder-Wanner; W Kaiser
Journal:  Psychol Med       Date:  2000-01       Impact factor: 7.723

4.  The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale.

Authors:  R M Norman; A K Malla; T McLean; L P Voruganti; L Cortese; E McIntosh; S Cheng; A Rickwood
Journal:  Acta Psychiatr Scand       Date:  2000-10       Impact factor: 6.392

5.  Rehabilitation and quality of life.

Authors:  N Sartorius
Journal:  Hosp Community Psychiatry       Date:  1992-12

6.  A rating scale for drug-induced akathisia.

Authors:  T R Barnes
Journal:  Br J Psychiatry       Date:  1989-05       Impact factor: 9.319

7.  Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology.

Authors:  M Atkinson; S Zibin; H Chuang
Journal:  Am J Psychiatry       Date:  1997-01       Impact factor: 18.112

8.  Subject and observer-rated quality of life in schizophrenia.

Authors:  P B Fitzgerald; C L Williams; N Corteling; S L Filia; K Brewer; A Adams; A R de Castella; T Rolfe; P Davey; J Kulkarni
Journal:  Acta Psychiatr Scand       Date:  2001-05       Impact factor: 6.392

9.  Self-report quality of life measure for people with schizophrenia: the SQLS.

Authors:  G Wilkinson; B Hesdon; D Wild; R Cookson; C Farina; V Sharma; R Fitzpatrick; C Jenkinson
Journal:  Br J Psychiatry       Date:  2000-07       Impact factor: 9.319

10.  A new depression scale designed to be sensitive to change.

Authors:  S A Montgomery; M Asberg
Journal:  Br J Psychiatry       Date:  1979-04       Impact factor: 9.319

View more
  8 in total

1.  The RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophrenia.

Authors:  M Riedel; I Spellmann; R Schennach-Wolff; M Obermeier; R Musil
Journal:  Qual Life Res       Date:  2010-10-05       Impact factor: 4.147

Review 2.  Measuring quality of life in patients with schizophrenia: an update.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  Pharmacoeconomics       Date:  2012-03       Impact factor: 4.981

3.  Systematic review of global functioning and quality of life in people with psychotic disorders.

Authors:  A G Nevarez-Flores; K Sanderson; M Breslin; V J Carr; V A Morgan; A L Neil
Journal:  Epidemiol Psychiatr Sci       Date:  2018-10-01       Impact factor: 6.892

4.  Assessing the efficacy of a modified assertive community-based treatment programme in a developing country.

Authors:  Ulla A Botha; Liezl Koen; John A Joska; Linda M Hering; Piet P Oosthuizen
Journal:  BMC Psychiatry       Date:  2010-09-15       Impact factor: 3.630

5.  Predictors of general quality of life and the mediating role of health related quality of life in patients with schizophrenia.

Authors:  Carin J Meijer; Maarten W J Koeter; Mirjam A G Sprangers; Aart H Schene
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-10-30       Impact factor: 4.328

6.  Dimensional symptom severity and global cognitive function predict subjective quality of life in patients with schizophrenia and healthy adults.

Authors:  Pamela DeRosse; George C Nitzburg; Melanie Blair; Anil K Malhotra
Journal:  Schizophr Res       Date:  2017-10-19       Impact factor: 4.939

7.  Validity of subjective versus objective quality of life assessment in people with schizophrenia.

Authors:  Karen P Hayhurst; Jennifer A Massie; Graham Dunn; Shôn W Lewis; Richard J Drake
Journal:  BMC Psychiatry       Date:  2014-12-24       Impact factor: 3.630

8.  Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms.

Authors:  Breno F Cruz; Camilo B de Resende; Carolina F Carvalhaes; Clareci S Cardoso; Antonio L Teixeira; Richard S Keefe; Fábio L Rocha; João V Salgado
Journal:  Braz J Psychiatry       Date:  2016-06-14       Impact factor: 2.697

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.